Gabelli is out with its report today on Meredith MDP, maintaining Hold.
In a note to clients, Gabelli writes, "MDP is well-run and its businesses generate free cash. The roughly $7 per share decline in the stock price over the last six months leaves MDP trading at about 6.1x current year EBITDA. We calculate a $42 per share FY 2012 PMV, based on 7x EBITDA. The possibility of a (larger) share buyback could be a catalyst, and at current prices the stock is getting more interesting."
At the time of posting, shares of MDP were trading at $30.61, up 1.49% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in